C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings

Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
12/2006
12/20/2006	EP1188745B1 Heterocyclic dicarboxylic acid diamide derivatives, agricultural/horticultural insecticides and method of using the same
12/20/2006	CN1882553A Phenylacetic acid derivative, process for producing the same, and use
12/14/2006	WO2006133326A1 Inhibitors of hcv replication
12/14/2006	WO2006132173A1 Organic metal complex and organic electroluminescent device using same
12/14/2006	WO2006131233A1 Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
12/14/2006	WO2006102674A3 Diphenylheterocycle cholesterol absorption inhibitors
12/14/2006	US20060281799 8-({5-[4-(trifluoromethyl)phenyl]-1,3-oxazol-2-yl}amino)-3,4-dihydronaphthalen-2(1H) one; treating pain, bladder overactivity, and urinary incontinence
12/14/2006	US20060281762 1,3-Benzoxazolyl derivatives as kinase inhibitors
12/14/2006	US20060281736 Product comprising at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
12/14/2006	DE102005026808A1 Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen Benzooxazol-2-one derivatives as inhibitors of lipases, and phospholipases
12/14/2006	CA2609815A1 Benzooxazole-2-on derivatives as lipase and phospholipase inhibitors
12/13/2006	EP1731513A1 Phenoxyacetic acid derivative and medicine containing the same
12/13/2006	EP1730148A2 Aminobenzoxazoles as therapeutic agents
12/13/2006	EP1730130A1 Beta-ketoamide compounds having an mch-antagonistic effect and medicaments containing said compounds
12/13/2006	EP1730128A1 Anaplastic lymphoma kinase modulators and methods of use
12/13/2006	EP1729774A1 Pyrrolidine compounds
12/13/2006	EP1425014B1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
12/13/2006	EP1294823B1 Double-spiro organic compounds and electroluminescent devices
12/13/2006	CN1878777A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis
12/13/2006	CN1878554A 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses
12/13/2006	CN1876664A Organometallic complex and organic electroluminescent device using the same
12/13/2006	CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006	CN1289467C Dibenzylamine compound and medicinal use thereof
12/13/2006	CN1289083C 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
12/13/2006	CN1289082C Medicine composition for treating diabetes
12/12/2006	US7148259 hydroxyamidines; antibiotic resistance
12/12/2006	US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006	US7148246 Therapy, prevention diseases of fatty acid metabolism, glucose utilization; insulin resistance; antidiabetic agents; antilipemic agents
12/12/2006	US7148232 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
12/12/2006	US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7148219 Biaryl heterocyclic compounds and methods of making and using the same
12/12/2006	CA2281695C Process for the preparation of substituted thiazolidinedione
12/07/2006	WO2006129649A1 Processes for production of optically active ppar-activating compounds and intermediates for production thereof
12/07/2006	WO2006129164A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
12/07/2006	WO2006058088A3 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
12/07/2006	US20060276656 Method for the production of fluoromethyl-substituted heterocycles
12/07/2006	US20060276518 Aryl and heteroaryl compounds and methods to modulate coagulation
12/07/2006	US20060276433 Hydrazone derivative
12/06/2006	EP1728784A1 Fluorene derivative
12/06/2006	EP1727796A2 Palladium catalyzed indolization of 2-bromo or chloroanilines
12/06/2006	EP1599433B1 Method for producing the enantiomeric forms of cis 1,3-cyclohexanediol derivatives
12/06/2006	CN1875006A Method for the production of fluoromethyl-substituted heterocycles
12/06/2006	CN1874996A Aminopropanol derivatives
12/06/2006	CN1874770A Therapeutic agent for keratoconjunctiva disorder
12/05/2006	US7144911 Anti-inflammatory medicaments
12/05/2006	US7144906 Heterocyclic compounds
12/05/2006	US7144900 Pharmaceutical composition
12/05/2006	US7144893 4-aryl quinols and analogs thereof as therapeutic agents
12/05/2006	US7144888 Vanilloid receptor ligands and their use in treatments
12/05/2006	CA2531834C Pharmaceutical compositions comprising pioglitazone and an insulin secretion enhancer
11/2006
11/30/2006	WO2006127909A2 Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate
11/30/2006	WO2006127893A2 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
11/30/2006	WO2006125687A1 Heteroaroyl-substituted serine amides
11/30/2006	WO2006125337A1 α, β- AND, Ϝ-UNSATURATED CARBOXYLATES AND THE USE AS HERBICIDIDE THEREOF
11/30/2006	WO2006110155A8 Solid forms of linezolid and processes for preparation thereof
11/30/2006	WO2006103045B1 Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
11/30/2006	WO2006094770A3 Apparatus and method for the final processing of a forming tool for a sheet-metal body part
11/30/2006	WO2006017409A3 1,3-disubstituted heteroaryl nmda/nr2b antagonists
11/30/2006	US20060270851 Production process of optically pure 2-(4- hydroxyphenoxy)-propionic acid compounds
11/30/2006	US20060270721 EP4 receptor agonist, compositions and methods thereof
11/30/2006	US20060270710 Methods for inhibition of angiogenesis
11/30/2006	US20060270680 Sulfonamide compounds and methods of making and using the same
11/30/2006	US20060270651 Antibacterial agents
11/30/2006	US20060270588 Organic compounds
11/30/2006	CA2609511A1 Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate
11/30/2006	CA2609506A1 Processes for production of 4-(biphenylyl)azetidin-2-one phosphonic acids
11/30/2006	CA2609243A1 Heteroaroyl-substituted serine amides
11/29/2006	EP1726586A1 Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
11/29/2006	EP1725549A1 Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
11/29/2006	EP1725524A1 Substituted heteroaryl- and phenylsulfamoyl compounds
11/29/2006	EP1651642A4 Pna monomer and precursor
11/29/2006	EP1076053B1 3-arylphenyl sulfide derivatives and insecticides and miticides
11/29/2006	CN1871222A Ccr3受体拮抗剂 Ccr3 receptor antagonists
11/29/2006	CN1870988A 2-azetidinones as anti-hypercholesterolemic agents
11/29/2006	CN1869028A Preparation method of 2-(4-hydroxy benzoxy) 6-chlorobenzene diozaiole
11/29/2006	CN1286824C Paro methylsulfonyl phongl acrylic acid derivative and its preparation method and antiinflammation action
11/29/2006	CN1286823C Oxazolidine intermediate for preparing taxad alkane
11/28/2006	US7141672 Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
11/28/2006	US7141655 Reagents and procedures for high-specificity labeling
11/28/2006	US7141588 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
11/28/2006	US7141570 antimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium
11/28/2006	US7141533 optionally substituted thiazolyl, oxazolyl or pyrazolyl substituted heterocycles; use as pesticides and herbicides
11/23/2006	WO2006122949A1 Malononitriles and their use as pesticides
11/23/2006	WO2006106437A3 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
11/23/2006	WO2006105217A3 Spirocyclic thrombin receptor antagonists
11/23/2006	WO2006081034A3 Anti-inflammatory medicaments
11/23/2006	US20060264673 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/23/2006	US20060264643 One Pot Synthesis of 2-Oxazolidinone Derivatives
11/23/2006	US20060264630 Antidiabetic agents; modulate insulin drug resistance
11/23/2006	US20060264483 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060264426 Antiinfective agent, antiproliferation agent, antiinflammatory agent or prokinetics
11/23/2006	US20060264403 phosphoric acid mono-[2-hydroxymethyl-4-(4-octyl-phenyl)-2-(1-oxo-1,3-dihydro-isoindol-2-yl)-butyl] ester; disorders mediated by lymphocytes interactions like transplant rejection, graft versus host disease, autoimmune diseases; binding affinity to Sphingosine-1-phosphate(S1P) receptors
11/23/2006	US20060263928 Assembly of a semiconductor die attached to substrate with oxazoline derivative bearing an electron donor or acceptor functionality
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1723122A2 Dimeric small molecule potentiators of apoptosis
11/22/2006	EP1722863A1 Microcapsules with uv filter activity and process for producing them
11/22/2006	EP1722793A1 Bicyclic modulators of androgen receptor function
11/22/2006	CN1867554A Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors

1 ... 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 ... 210